22 results
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:18pm
mission to allow patients to manage and control the negative symptoms and progression of kidney disease.
XORTX Competitive Advantage
We are led
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:11pm
mission to allow patients to manage and control the negative symptoms and progression of kidney disease.
XORTX Competitive Advantage
We are led
6-K
EX-99.1
XRTX
XORTX Therapeutics Inc
7 Sep 23
XORTX Joins the Kidney Foundation and Kidney March
8:23am
; Increasing public awareness and commitment to advancing kidney health and organ donation. https://kidney.ca/About-Us/Overview/Our-Mission
About
6-K
EX-99.3
spm0aubwcy
3 Apr 23
Consolidated Financial Statements
6:05am
424B4
dh2n6n79cbeq2v
5 Oct 22
Prospectus supplement with pricing info
5:24pm
POS AM
n6o1aegzird cb
29 Sep 22
Prospectus update (post-effective amendment)
9:49pm
F-1/A
chngi4
21 Sep 22
Registration statement (foreign) (amended)
4:20pm
F-1
astlb7
8 Sep 22
Registration statement (foreign)
1:02pm
DRS
3q8 s4b92qvz88au24
15 Aug 22
Draft registration statement
12:00am
20-F
m8eb1ql
3 May 22
Annual report (foreign)
5:29pm
20-F
EX-4.19
vagietsv azz0oqo050
3 May 22
Annual report (foreign)
5:29pm
6-K
EX-99.1
wz84n1jpah9sv 50m
13 Apr 22
Current report (foreign)
7:23am
6-K
EX-99.1
azpfxemcuy rkymoz1ya
2 Dec 21
XORTX Therapeutics Appoints Altasciences as CRO for Clinical Study
7:46am
424B4
m8q9hjr5
14 Oct 21
Prospectus supplement with pricing info
4:30pm
F-1/A
f9bl t7vg0n6q7qfbv8
4 Oct 21
Registration statement (foreign) (amended)
12:00am
F-1/A
igngjw96lxl5wnjo
16 Sep 21
Registration statement (foreign) (amended)
5:16pm
F-1
bn3z4wmu4
11 Aug 21
Registration statement (foreign)
9:55pm
DRS/A
zb143b71i
21 Jul 21
Draft registration statement (amended)
12:00am